.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Teva
US Department of Justice
Medtronic
Novartis
Federal Trade Commission
AstraZeneca
Covington
Farmers Insurance
Cerilliant

Generated: December 17, 2017

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Denmark Patent: 200601223

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Takeda Pharms UsaTRINTELLIXvortioxetine hydrobromideTABLET;ORAL204447-001Sep 30, 2013RXYesNo► Subscribe► SubscribeMETHOD OF TREATING DEPRESSION OR MAJOR DEPRESSIVE DISORDER
Takeda Pharms UsaTRINTELLIXvortioxetine hydrobromideTABLET;ORAL204447-002Sep 30, 2013RXYesNo► Subscribe► SubscribeMETHOD OF TREATING DEPRESSION OR MAJOR DEPRESSIVE DISORDER
Takeda Pharms UsaTRINTELLIXvortioxetine hydrobromideTABLET;ORAL204447-003Sep 30, 2013DISCNYesNo► Subscribe► SubscribeMETHOD OF TREATING DEPRESSION OR MAJOR DEPRESSIVE DISORDER
Takeda Pharms UsaTRINTELLIXvortioxetine hydrobromideTABLET;ORAL204447-004Sep 30, 2013RXYesYes► Subscribe► SubscribeMETHOD OF TREATING DEPRESSION OR MAJOR DEPRESSIVE DISORDER
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist